Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Proteomics-informed prediction of rosuvastatin plasma profiles in patients with a wide range of body weight.

Wegler, C., Prieto Garcia, L., Klinting, S., Robertsen, I., Wiśniewski, J. R., Hjelmesaeth, J., et al. (2021). Proteomics-informed prediction of rosuvastatin plasma profiles in patients with a wide range of body weight. Clinical pharmacology and therapeutics, 109(3), 762-771. doi:10.1002/cpt.2056.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel

Dateien

einblenden: Dateien
ausblenden: Dateien
:
cpt.2056.pdf (Verlagsversion), 917KB
Name:
cpt.2056.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Öffentlich
MIME-Typ / Prüfsumme:
application/pdf / [MD5]
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
© 2020 The Authors.
:
cpt2056-sup-0001-supinfos1.xlsx (Ergänzendes Material), 13KB
Name:
cpt2056-sup-0001-supinfos1.xlsx
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Öffentlich
MIME-Typ / Prüfsumme:
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet / [MD5]
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
-
Lizenz:
-
:
cpt2056-sup-0002-supinfos2.pdf (Ergänzendes Material), 3MB
Name:
cpt2056-sup-0002-supinfos2.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Öffentlich
MIME-Typ / Prüfsumme:
application/pdf / [MD5]
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
-
Lizenz:
-

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Wegler, Christine1, Autor
Prieto Garcia, Luna1, Autor
Klinting, Signe1, Autor
Robertsen, Ida1, Autor
Wiśniewski, Jacek R.2, Autor           
Hjelmesaeth, Joran1, Autor
Asberg, Anders1, Autor
Jansson-Lofmark, Rasmus1, Autor
Andersson, Tommy B1, Autor
Artursson, Per1, Autor
Affiliations:
1external, ou_persistent22              
2Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565159              

Inhalt

einblenden:
ausblenden:
Schlagwörter: HEK293 cells; Rosuvastatin; hepatic uptake activity; pharmacokinetics; protein quantification
 Zusammenfassung: Rosuvastatin is a frequently used probe to study transporter-mediated hepatic uptake. Pharmacokinetic models have therefore been developed to predict transporter impact on rosuvastatin disposition in vivo. However, the inter-individual differences in transporter concentrations were not considered in these models, and the predicted transporter impact was compared with historical in vivo data. In this study, we investigated the influence of inter-individual transporter concentrations on the hepatic uptake clearance of rosuvastatin in 54 patients covering a wide range of body weight. The 54 patients were given an oral dose of rosuvastatin the day before undergoing gastric bypass or cholecystectomy, and pharmacokinetic parameters were established from each patient's individual time-concentration profiles. Liver biopsies were sampled from each patient and their individual hepatic transporter concentrations were quantified. We combined the transporter concentrations with in vitro uptake kinetics determined in HEK293-transfected cells, and developed a semi-mechanistic model with a bottom-up approach to predict the plasma concentration profiles of the single dose of rosuvastatin in each patient. The predicted pharmacokinetic parameters were evaluated against the measured in vivo plasma pharmacokinetics from the same 54 patients. The developed model predicted the rosuvastatin pharmacokinetics within two-fold error for rosuvastatin AUC (78% of the patients; AFE: 0.96), Cmax (76%; AFE: 1.05), and t1/2 (98%; AFE: 0.89), and captured differences in the rosuvastatin pharmacokinetics in patients with the OATP1B1 521T<C polymorphism. This demonstrates that hepatic uptake clearance determined in transfected cell lines, together with proteomics scaling, provides a useful tool for prediction models, without the need for empirical scaling factors. This article is protected by copyright. All rights reserved.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 20202021
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: ISI: 32970864
DOI: 10.1002/cpt.2056
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Clinical pharmacology and therapeutics
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 109 (3) Artikelnummer: - Start- / Endseite: 762 - 771 Identifikator: ISSN: 1532-6535